tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Medical Marijuana'

Nuvilex, Inc. Engaged in “Cutting Edge” Cannabis Preclinical Studies Using Model Compounds with Cell-in-a-Box

Written by Ι Stock Market Media Group Staff — October 29, 2014

New York, NY – Nuvilex, Inc. (OTCQB: NVLX) isn’t letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its research.  The company is currently engaged in preclinical studies at the University of Northern Colorado (UNC) targeting Cannabis-based cancer treatments using Nuvilex’s Cell-in-a-Box® cellulose-based live cell encapsulation technology. 

While waiting for a Schedule 1 license from the DEA in order to conduct research using marijuana, Dr. ...

Read More →
0

Plandai Biotechnology Receives Approval to Grow Cannabis for Medical Research from Uruguay’s Minister of Public Health

Plandai Biotechnology Receives Approval to Grow Cannabis for Medical Research from Uruguay’s Minister of Public Health

SEATTLE, WA — October 29, 2014 — Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that Uruguay’s Ministry of Public Health has approved an academic collaboration between Plandaí and the Group of Medicinal Chemistry from the School of Science at the University of the Republic (“University”) in Montevideo, Uruguay.  The approval, issued in September 2014, allows Plandaí to grow cannabis in conjunction with ...

Read More →
0

Plandaí Biotechnology to Acquire License to Diego Pellicer Brand for Medical & Pharmaceutical Cannabis Extracts

Plandaí Biotechnology to Acquire License to Diego Pellicer Brand for Medical & Pharmaceutical Cannabis Extracts
Executes Agreement in Anticipation of Launching Diego Pellicer Gold™ Cannabinoid Extracts

SEATTLE, WA — January 16, 2014 – Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it has entered into an agreement with Diego Pellicer, Inc. and Diego Pellicer Worldwide Inc. which will permit the company use of the Diego Pellicer name for its Phytofare™ cannabis extracts in medical and pharmaceutical marijuana applications.

Diego ...

Read More →
0

Plandai Biotechnology’s Medical Marijuana Subsidiary Will Introduce Marijuana Industry to Unzipping Molecules

Plandai Biotechnology’s Medical Marijuana Subsidiary Will Introduce Marijuana Industry to Unzipping Molecules

Written by ι Stock Market Media Group Staff — January 15, 2014

Plandaí Biotechnology, Inc. (OTCQB: PLPL) could hold the key to making what is a miracle drug for some, into an even more powerful miracle drug for many.  The company entered the medical marijuana industry with its wholly-owned subsidiary, Cannabis Biosciences, Inc., for the purpose of developing and testing a new Phytofare™ botanical extract derived from cannabis.  Researchers may quickly find that Plandaí’s “hydrodynamic sheering” process could deliver an extract that ...

Read More →
0

New Study Continues to Validate Nuvilex’s Approach to Medical Marijuana Research

New Study Continues to Validate Nuvilex’s Approach to Medical Marijuana Research

Written by ι Stock Market Media Group Staff — October 22, 2013

Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary, Medical Marijuana Sciences, Inc., received another validation of their efforts to bring research utilizing cannabidiol (CBD) as the basis for developing treatments for some of the deadliest forms of cancer to the industry.  This latest study serves as another piece of evidence in a mounting argument that cannabinoids from Cannabis, such as CBD, are effective anti-cancer drugs.   

It was a team at St ...

Read More →
0

Nuvilex, Inc.’s Marijuana Research into Cannabidiol Could Lead to Many Successes

Nuvilex, Inc.’s Marijuana Research into Cannabidiol Could Lead to Many Successes

Written by ι Stock Market Media Group Staff — October 3, 2013

Nuvilex, Inc. (OTCQB: NVLX) formed its subsidiary, Medical Marijuana Sciences, Inc., to study the medical applications of marijuana, and more specifically, it has chosen to focus its initial research on utilizing cannabidiol, or CBD, one of the compounds found in Cannabis, as the basis for developing treatments for serious and deadly forms of cancer.  The company wants to use its expertise, current research and its success in the biotechnology sector ...

Read More →
0
Page 1 of 3 123
ContactUs.com